BIOMAT Database Logo BIOMAT Database Logo

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis. 1998

B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Service d'Hépato-Gastroentérologie, Hôpital Pitié-Salpêtrière, Paris, France.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D016905 Gram-Negative Bacterial Infections Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method. Bacterial Infections, Gram-Negative,Infections, Gram-Negative Bacterial,Bacterial Infection, Gram-Negative,Gram Negative Bacterial Infections,Gram-Negative Bacterial Infection,Infection, Gram-Negative Bacterial

Related Publications

B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal hemorrhage.
August 2002, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials.
February 2003, Scandinavian journal of gastroenterology,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding.
April 2009, The Cochrane database of systematic reviews,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
September 1998, Journal of hepatology,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
October 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review.
September 2011, Alimentary pharmacology & therapeutics,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Albumin for cirrhotic patients with extraperitoneal infections: A meta-analysis.
December 2019, Journal of gastroenterology and hepatology,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding.
January 2002, The Cochrane database of systematic reviews,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Bacterial growth and antibiotic resistance patterns in cirrhotic ascites.
October 2017, Infection,
B Bernard, and J D Grangé, and E N Khac, and X Amiot, and P Opolon, and T Poynard
Secondary bacterial peritonitis in cirrhotic patients with ascites.
May 1984, Southern medical journal,
Copied contents to your clipboard!